Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Cancer Type/Condition:  Skin cancer, melanoma
Stage/Subtype:  stage 0 melanoma
Trial Type:  Treatment
Results 1-1 of 1 for your search:
Start Over
Neoadjuvant X4P-001 and Pembrolizumab in Patients With Resectable Melanoma
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: X4P-001-MELA, NCI-2016-01133, NCT02823405
Start Over